Point-of-Care Diagnostics Market | Growth Opportunities, Trends & Key Insights 2025-2033 | Quidel Corporation, BioMérieux SA, OraSure Technologies, Inc.

The Global Point-of-Care Diagnostics Market reached US$ 42.3 billion in 2023 and is expected to reach US$ 107.3 billion by 2033, growing at a CAGR of 9.6% during the forecast period 2025-2033.

Point-of-Care Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/point-of-care-diagnostics-market?sj

The Point-of-Care Diagnostics Market focuses on portable testing devices that enable rapid diagnosis outside traditional clinical settings, such as at home, in pharmacies, or at remote locations. These diagnostics provide quick results for conditions like diabetes, infections, and heart disease. Advancements in technology, the growing need for accessible healthcare, and a focus on early disease detection are driving market growth globally.

List of the Key Players in the Point-of-Care Diagnostics Market:

Abbott Laboratories, Becton, Dickinson and Company (BD), QIAGEN, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Quidel Corporation, BioMérieux SA, OraSure Technologies, Inc, Trinity Biotech and among others.

Industry Development:

In November 2024, PixCell Medical received certification for its HemoScreen CBC analyzer under the In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746. This FDA-cleared, point-of-care 5-part differential Complete Blood Count (CBC) analyzer is the first of its kind to meet the stringent IVDR requirements, reinforcing PixCell Medical's leadership in advancing rapid, accurate, and portable diagnostic solutions to enhance patient care.

In April 2024, Roche Diagnostics India launched its point-of-care (PoC) NT-proBNP test for screening diabetes patients at risk of cardiovascular diseases, such as heart failure. Available exclusively on the Cobas H 232 system, this innovative test offers faster and more efficient diagnosis and management of heart failure in type 2 diabetes patients, transforming the approach to patient care.

Growth Forecast Projected:

The Global Point-of-Care Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Point-of-Care Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/point-of-care-diagnostics-market

Segment Covered in the Point-of-Care Diagnostics Market:

By Product Type: Glucose Monitoring Kits, Infectious Disease Testing Kits, Cardiometabolic Monitoring Kits, Pregnancy and Fertility Testing Kits, Hematology Testing Kits, Urinalysis Kits, Tumor/Cancer Markers, Drugs-of-Abuse Testing Kits, Others.

By Technology: Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Microfluidics, Others.

By Application: Infectious Diseases, Cardiology, Oncology, Endocrinology, Hematology, Neurology, Drug Testing, Others.

By End User: Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Ambulatory Surgery Centers (ASCs).

Regional Analysis for Point-of-Care Diagnostics Market:

The regional analysis of the Point-of-Care Diagnostics Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/point-of-care-diagnostics-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Point-of-Care Diagnostics market?

➠ Who are the leading manufacturers in the global Point-of-Care Diagnostics industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Point-of-Care Diagnostics industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Point-of-Care Diagnostics market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/point-of-care-diagnostics-market

Blood Culture Tests Market: https://www.datamintelligence.com/research-report/blood-culture-tests-market

Blood Group Typing Market: https://www.datamintelligence.com/research-report/blood-group-typing-market

Sepsis Diagnostic Market: https://www.datamintelligence.com/research-report/sepsis-diagnostic-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.